retatrutide clinical trials retatrutide mechanism (RETA-10) 112mg Research Peptide retatrutide-and-cagrilintide-15mg-5mg

PubMed Thomas, M.K., Nikooienejad, A., Bray, R., Cui, X., Wilson, J., Duffin, K., et al

Retatrutide acts as a triple incretin receptor agonist, simultaneously activating three distinct receptors: GLP-1 receptors stimulating insulin secretion in a glucose-dependent manner, slowing gastric emptying, and reducing appetite GIP receptors enhancing insulin release and potentially improving fat metabolism Glucagon receptors increasing energy expenditure and promoting fat breakdown in the liver This multi-receptor activity produces pronounced effects on body weight, blood glucose, lipid metabolism, and hepatic fat

Karanfil iyi bir idrar sktrcdr

doi:10.1016/j.ejphar.2015.09.024 87